BRAF V600E is an actionable mutation in melanoma with significantly prolonged survival when a BRAF inhibitor is administered in patients with this mutation [25], but it is not actionable in colorectal adenocarcinoma. Here, BRAF is linked to colorectal adenocarcinoma.